論文 - 詳細
| RRC ID | 18646 |
|---|---|
| 著者 | Yoshida H, Sumi T, Zhi X, Yasui T, Honda K, Ishiko O. |
| タイトル | Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer. |
| ジャーナル | Anticancer Res |
| Abstract |
BACKGROUND:Claudin-4, a component of the tight junction, plays an important role in tumorigenesis and metastasis of ovarian cancer, but its role in platinum resistance has not been elucidated. MATERIALS AND METHODS:Claudin-4 expression in ovarian cancer cells was inhibited and the changes in cisplatin sensitivity were examined. Fluorescence-labeled cisplatin was used to examine whether inhibition of claudin-4 changed the cellular accumulation of cisplatin. Claudin-4 expression in ovarian cancer tissue resected from the patients surgically was evaluated immunohistochemically. RESULTS:Suppression of claudin-4 resulted in a significant increase of cisplatin sensitivity and cellular accumulation of fluorescence-labeled cisplatin. Claudin-4 expression was significantly greater in ovarian cancer tissue from chemoresistant patients compared to chemosensitive patients. The overall survival was significantly shorter for claudin-4-positive than claudin-4-negative cases. CONCLUSION:These data suggest that claudin-4 contributes to platinum resistance in ovarian cancer and may be a potential target in the treatment of platinum-resistant tumors. |
| 巻・号 | 31(4) |
| ページ | 1271-7 |
| 公開日 | 2011-4-1 |
| PII | 31/4/1271 |
| PMID | 21508375 |
| MeSH | Adenocarcinoma, Clear Cell / drug therapy Adenocarcinoma, Clear Cell / metabolism Adenocarcinoma, Clear Cell / pathology Adenocarcinoma, Mucinous / drug therapy Adenocarcinoma, Mucinous / metabolism Adenocarcinoma, Mucinous / pathology Antineoplastic Agents / therapeutic use* Cell Line, Tumor Cisplatin / therapeutic use* Claudin-4 Cystadenocarcinoma, Serous / drug therapy Cystadenocarcinoma, Serous / metabolism Cystadenocarcinoma, Serous / pathology Drug Resistance, Neoplasm* Endometrial Neoplasms / drug therapy Endometrial Neoplasms / metabolism Endometrial Neoplasms / pathology Female Fluorescent Antibody Technique Humans Immunoenzyme Techniques Membrane Proteins / metabolism* Middle Aged Ovarian Neoplasms / drug therapy* Ovarian Neoplasms / metabolism* Ovarian Neoplasms / pathology Survival Rate Treatment Outcome |
| IF | 1.994 |
| 引用数 | 27 |
| WOS 分野 | ONCOLOGY |
| リソース情報 | |
| ヒト・動物細胞 | NIH:OVCAR-3(RCB2135) |